CONCLUSIONS	Therapy with celecoxib for up to 14 days did not have a greater relapse rate than placebo in patients with ulcerative colitis in remission who had a present or past history of nonspecific arthritis , arthralgia , or other condition amenable to nonsteroidal anti-inflammatory drug therapy .\